UM1TR005436
Cooperative Agreement
Overview
Grant Description
CTSA UM1 AT DUKE UNIVERSITY - THE MISSION OF THE DUKE CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI), HOME TO THE CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) SINCE 2006, IS TO CATALYZE TRANSLATIONAL SCIENCE IN WAYS THAT EFFECTIVELY AND EFFICIENTLY BRING MEDICAL DISCOVERIES TO SOCIETY. IN THE NEXT PHASE OF OUR CTSA, WE ARE POISED TO BUILD ON ESTABLISHED PROGRAMS AND CAPABILITIES TO MARKEDLY INCREASE OUR IMPACT. HOWEVER, WE ARE ACUTELY AWARE OF THE CHALLENGES POSED BY THE INCREASING DOUBTS ABOUT THE CREDIBILITY OF MEDICAL SCIENCE. IN RESPONSE TO DIMINISHED TRUST IN SCIENCE AND MEDICAL INSTITUTIONS AND DRIVEN BY OUR FIERCE COMMITMENT TO IMPROVE HEALTH FOR ALL, WE WILL FOCUS THE NEXT PHASE OF OUR CTSA ON “TRUSTWORTHY PARTNERSHIPS TO IMPROVE HEALTH THROUGH TRANSLATIONAL SCIENCE.” TO ENSURE THAT THE BENEFITS OF CLINICAL AND TRANSLATIONAL RESEARCH (CTR) ARE ACCESSIBLE TO ALL, WE WILL CENTER OUR PROGRAMS ON THE FOUNDATIONAL PRINCIPLES OF TRUSTWORTHINESS AND MEANINGFUL ENGAGEMENT OF PARTNERS AND THE COMMUNITY THAT INCLUDE BIDIRECTIONAL COMMUNICATION, SHARED RESOURCES AND DECISION MAKING, ATTENTION TO BALANCING POWER DYNAMICS, AND RESPECT FOR BROAD EXPERTISE AND EXPERIENCES. TOGETHER, WITH OUR PARTNERS AND COLLABORATORS, WE WILL: (1) CATALYZE INNOVATIONS THAT ADVANCE CLINICAL AND TRANSLATIONAL SCIENCE, (2) CULTIVATE AND DISSEMINATE A SUITE OF BEST- IN-CLASS RESEARCH SERVICES AND RESOURCES THAT ENABLES INVESTIGATORS AND PARTNERS TO CONDUCT EFFICIENT, EFFECTIVE RESEARCH ACROSS THE TRANSLATIONAL SPECTRUM, (3) CREATE, NURTURE, AND ADVANCE COMMUNITY-PARTNERED RESEARCH TO IMPROVE HEALTH FOR ALL ACROSS THE LIFESPAN, (4) TRAIN AND DEVELOP AN INTERPROFESSIONAL CLINICAL AND TRANSLATIONAL RESEARCH WORKFORCE PREPARED TO IMPLEMENT TRUSTWORTHY RESEARCH PROGRAMS THAT RAPIDLY TRANSLATE DISCOVERIES TO PRACTICE, AND (5) PROPAGATE AN INFORMATICS FRAMEWORK THAT ENHANCES DATA ACCESS, DATA TRANSPARENCY, AND THE TRUSTWORTHY APPLICATION OF BIOSTATISTICS, DATA SCIENCE, AND ARTIFICIAL INTELLIGENCE. WE WILL STUDY THE IMPACT OF OUR EFFORTS AND IDENTIFY EFFECTIVE APPROACHES TO FACILITATE THE ACHIEVEMENT OF IMPROVED HEALTH FOR ALL. WE WILL ALSO IMPLEMENT NEW PROCEDURES FOR MEASURING HEALTH IN OUR COMMUNITY. WE WILL DISSEMINATE GENERALIZABLE NOVEL APPROACHES AND PRACTICES THROUGHOUT THE CTSA CONSORTIUM AND BEYOND, CATALYZING EFFORTS TO IMPROVE HEALTH ACROSS OUR NATION.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
North Carolina
United States
Geographic Scope
State-Wide
Duke University was awarded
Trustworthy Partnerships for Health: Advancing Translational Science
Cooperative Agreement UM1TR005436
worth $9,863,911
from National Center for Advancing Translational Sciences in August 2025 with work to be completed primarily in North Carolina United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
8/15/25
Start Date
7/31/32
End Date
Funding Split
$9.9M
Federal Obligation
$0.0
Non-Federal Obligation
$9.9M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
UM1TR005436
SAI Number
UM1TR005436-2903398793
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
TP7EK8DZV6N5
Awardee CAGE
4B478
Performance District
NC-90
Senators
Thom Tillis
Ted Budd
Ted Budd
Modified: 8/20/25